MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review. Sign up here to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
Arcmont raises €10bn for European direct-lending fund. (Financial Sponsors)?
Sanofi to buy US drugs project INBRX-101 for about $2.2bn.
You can access today’s complete newsletter here .
Scroll down for more…
Realty Income Corporation , a real estate investment trust that invests in free-standing, single-tenant commercial properties in the United States, Spain and the United Kingdom, completed the acquisition of Spirit Realty Capital, Inc (NYSE: SRC) , a net-lease REIT, investing primarily in single-tenant, operationally essential real estate assets, for $9.3bn.
"We are pleased to announce the completion of our merger with Spirit. The transaction, which is immediately accretive on a leverage neutral basis, is further evidence of how our unique platform and our position as global consolidator in the fragmented net lease space creates meaningful value for stockholders," Sumit Roy, Realty Income President and Chief Executive Officer.?
Spirit Realty Capital was advised by 摩根士丹利 , J.P. 摩根 (led by Chris Ventresca ), Wachtell, Lipton, Rosen & Katz (led by Adam Emmerich and Karessa Cain). Financial advisors are advised by Cravath, Swaine & Moore LLP (led by Minh Van Ngo). Realty Income was advised by Barclays , 富国银行 , and Latham & Watkins (led by Charles Ruck , Darren Guttenberg , and Bradley Helms ).
Amusement park operators Six Flags and Cedar Fair Entertainment Company , said they have received a request for additional information and documents from the US Department of Justice, which is reviewing a merger of the two companies, Reuters reported.?
The second request from DOJ in relation to the Six Flags and Cedar Fair merger comes at a time when deals in the US are facing anti-trust scrutiny from regulators, as well as consumer interest groups.
领英推荐
Six Flags is advised by Kirkland & Ellis (led by Sarkis Jebejian , Allie Wein and Emily Lichtenheld ), 高盛 (led by Timothy Ingrassia), Sullivan & Cromwell LLP (led by George Sampas ), and FGS Global (led by George Manolis ). Financial advisors are advised by Cravath, Swaine & Moore LLP (led by Keith Hallam and Jin?Kyu Baek). Cedar Fair is advised by Perella Weinberg (led by James Wappler ), Squire Patton Boggs (led by Cipriano Beredo ), Weil, Gotshal & Manges LLP (led by Michael J. Aiello ), and Joele Frank (led by Daniel Katcher ). Financial advisors are advised by Covington & Burling LLP (led by J.D. Weinberg).
百时美施贵宝 , a global biopharmaceutical company, completed the acquisition of Mirati Therapeutics , a commercial stage biotechnology company, for $4.7bn.
“The closing of the Mirati transaction is a significant milestone in our efforts to further diversify our oncology portfolio and strengthen our pipeline in the latter half of the decade and beyond. Mirati’s incredibly talented employees have built a strong portfolio of assets and capabilities that are highly complementary with BMS’. We welcome them and look forward to working together to leverage BMS’ global scale and resources to deliver more treatments for cancer patients, faster," Chris Boerner, Bristol Myers CEO.
Mirati Therapeutics was advised by Centerview Partners (led by Alan Hartman ) and Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates (led by Graham Robinson ) and FGS Global (led by Andrew Cole ). Financial advisors were advised by Paul, Weiss, Rifkind, Wharton & Garrison LLP . Bristol Myers was advised by Evercore (led by Francois Maisonrouge ), 摩根士丹利 (led by Clint Gartin), Arnold & Porter , Kirkland & Ellis (led by Jonathan Davis , Emily Lichtenheld and Daniel Wolf ), Wolf Theiss , Joele Frank (led by Daniel Katcher ). Financial advisors were advised by Sullivan & Cromwell LLP (led by Stephen Kotran )
Arcmont raises €10bn for European direct-lending fund. (FS)?
Arcmont Asset Management raised €10bn ($10.9bn) for its latest European direct-lending fund, the high end of its target range, as institutional investors show a growing preference for larger managers like the investment firm,?Bloomberg ?reported.
It’s the fourth fund devoted to London-based Arcmont’s direct-lending strategy. The company, an affiliate of investment heavyweight Nuveen, a TIAA company , has already committed about 55% of the capital.
Sanofi to buy US drugs project INBRX-101 for about $2.2bn.
French healthcare company Sanofi has agreed to buy US biotech firm Inhibrx Biosciences, Inc. in a deal valued at up to $2.2bn, bolstering its drug development portfolio with an experimental treatment for a rare genetic disease, Reuters reported.
The companies said the deal will give Sanofi access to Inhibrx's INBRX-101, currently in the second of three phases of clinical trials, while its other experimental drugs will be spun off into a separate company, with Sanofi retaining an 8% stake.
Interested to find more? Sign up here to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter here .